Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 233

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer

Open access
Lin, Ling-Yun, Yang, Li, Zeng, Qiang, Wang, Lin, Chen, Mao-Li, Zhao, Ze-Hang, Ye, Guo-Dong, Luo, Qi-Cong, Lv, Pei-Yu, Guo, Qi-Wei, Li, Bo-An, Cai, Jian-Chun, Cai, Wang-Yu · 2018 · Molecular Cancer

Abstract

Conventional tumor markers for non-invasive diagnosis of gastric cancer (GC) exhibit insufficient sensitivity and specificity to facilitate detection of early gastric cancer (EGC). We aimed to identify EGC-specific exosomal lncRNA biomarkers that are highly sensitive and stable for the non-invasive diagnosis of EGC. Hence, in the present study, exosomes from the plasma of five healthy individuals and ten stage I GC patients and from culture media of four human primary stomach epithelial cells and four gastric cancer cells (GCCs) were isolated. Exosomal RNA profiling was performed using RNA sequencing to identify EGC-specific exosomal lncRNAs. A total of 79 and 285 exosomal RNAs were expressed at significantly higher levels in stage I GC patients and GCCs, respectively, than that in normal controls. Through combinational analysis of the RNA sequencing results, we found two EGC-specific exosomal lncRNAs, lncUEGC1 and lncUEGC2, which were further confirmed to be remarkably up-regulated in exosomes derived from EGC patients and GCCs. Furthermore, stability testing demonstrates that almost all the plasma lncUEGC1 was encapsulated within exosomes and thus protected from RNase degradation. The diagnostic accuracy of exosomal lncUEGC1 was evaluated, and lncUEGC1 exhibited AUC values of 0.8760 and 0.8406 in discriminating EGC patients from healthy individuals and those with premalignant chronic atrophic gastritis, respectively, which was higher than the diagnostic accuracy of carcinoembryonic antigen. Consequently, exosomal lncUEGC1 may be promising in the development of highly sensitive, stable, and non-invasive biomarkers for EGC diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-018-0834-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 233

Metadata

Authors
Lin, L.-Y., Yang, L., Zeng, Q., Wang, L., Chen, M.-L., Zhao, Z.-H., Ye, G.-D., Luo, Q.-C., Lv, P.-Y., Guo, Q.-W., Li, B.-A., Cai, J.-C., & Cai, W.-Y.
Venue
Molecular Cancer
Published
2018-04-24
Volume
17
Issue
1
Pages
84-84
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2807152260
Cited by
233
References
1
FWCI
9.18
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. https://app.cochat.ai/papers/10.1186/s12943-018-0834-9
The paper
Lin, L.-Y., Yang, L., Zeng, Q., Wang, L., Chen, M.-L., Zhao, Z.-H., Ye, G.-D., Luo, Q.-C., Lv, P.-Y., Guo, Q.-W., Li, B.-A., Cai, J.-C., & Cai, W.-Y. (2018). Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Molecular Cancer. https://doi.org/10.1186/s12943-018-0834-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.